STUDIES OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE GENES IN INFANTS AND CHILDREN MANIFESTING PREMATURE PUBARCHE AND INCREASED ADRENOCORTICOTROPIN-STIMULATED DELTA(5)-STEROID LEVELS
H. Sakkalalkaddour et al., STUDIES OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE GENES IN INFANTS AND CHILDREN MANIFESTING PREMATURE PUBARCHE AND INCREASED ADRENOCORTICOTROPIN-STIMULATED DELTA(5)-STEROID LEVELS, The Journal of clinical endocrinology and metabolism, 81(11), 1996, pp. 3961-3965
Classic 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) deficiency co
ngenital adrenal hyperplasia (CAH) results from a mutation in the type
II 3 beta HSD gene encoding adrenal and gonadal 3 beta HSD. We invest
igated the type II and type I 3 beta HSD gene sequences in 15 infants
and children with premature pubarche (PP; mean/range of age at PP, 4/0
.08-9 yr) and elevated ACTH-stimulated Delta(5) precursor steroid leve
ls. Compared to Tanner I control subjects of similar age, ACTH-stimula
ted hormonal levels were at 2.3-10.7 SD for 17-hydroxypregnenolone (De
lta(5)-17P) in all PP subjects, at 2.2-17 SD for dehydroepiandrosteron
e (DHEA) and 2.4-5.6 SD for the Delta(5)-17P/cortisol(F) ratio in all
PP subjects except 1 infant, and at 2.3-10 SD for the DHEA/androstened
ione (Delta(4)-A) ratio in 8 PP subjects. Compared to Tanner II normal
children, the hormonal levels were at 3-8 SD for Delta(5)-17P in all
13 PP children, at 2.3-4.7 so for the Delta(5)-17P/F ratio in 6 PP chi
ldren, and at 2.3-6.5 SD for DHEA and 3.5-9 SD for the DHEA/Delta(4)-A
ratio in 7 PP children. Type II 3 beta HSD gene sequences, including
regions of a putative promoter, all exons (I, II, III, and IV), and ex
on-intron boundaries, were normal in all subjects. Sequences of the ty
pe I 3 beta HSD gene encoding extraadrenal and extragonadal 3 beta HSD
were normal in the 6 patients tested. The ACTH-stimulated Delta(5)-17
P levels and Delta(5)-17P/F ratios in the PP children without type II
3 beta HSD gene mutation were exceedingly lower than the respective re
ported hormonal data for children with 3 beta HSD deficiency CAH with
proven type II 3 beta HSD gene mutation. The ACTH-stimulated DHEA leve
ls and DHEA/Delta(4)-A ratios were not exceedingly different between t
he children with and without type II 3 beta HSD gene mutation. These f
indings suggest that the degree of ACTH-stimulated Delta(5) precursor
steroid abnormality, such as Delta(5)-17P levels up to 10 SD above the
normal mean level found in our PP patients, is not caused by a mild v
ariant of 3 beta HSD deficiency CAH resulting from type II or type I 3
beta HSD gene mutation. The hormonal criterion for ACTH-stimulated De
lta(5)-17P levels in patients with mild variant 3 beta HSD deficiency,
therefore, is predicted to be higher than 10 SD above the normal mean
value.